Trial Profile
Double-Blind, Placebo Controlled Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance in Healthy Adult Humans
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 May 2015
Price :
$35
*
At a glance
- Drugs BAX 555 (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 04 May 2015 New trial record